Lanyrd is undergoing maintenance.

3rd Peptides Conference

The global peptide therapeutics market is expected to reach a value of US$23.7B by 2020 as a result of their efficacy for treating a huge array of conditions including cancer, metabolic disorders, nervous system disorders and gastrointestinal disorders among others. As such, further research has been done to develop a rich pipeline of novel peptides.

SMi’s CPD-certified conference provides the perfect platform to discuss the latest innovations in the peptides industry and explore a number of pressing issues such as the use of Cell Penetrating Peptides (CPP), the challenges involved with oral peptides and novel technologies for development and improvement.